missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Adenovirus 9 E4-Orf1 Synthetic Peptide
Descripción
Adenovirus-9 E4 Orf1 Synthetic Peptide, PEP-0721, from Invitrogen.
Adenoviruses are DNA viruses generally widespread in nature that are frequently the cause of acute upper respiratory tract infections (i.e. common colds). 49 human adenovirus serotypes have been discovered and divided into six subgroups, A to E, based on observation. They are an important cause of respiratory illness, conjunctivitis, gastroenteritis, and have more recently been recognized as a potential cause of sexually transmitted diseases. Several types have oncogenic potential though most cause self-limiting febrile illnesses characterized by inflammation of conjunctivae and the respiratory tract. The virus can be isolated from the majority of tonsils/adenoids surgically removed, indicating latent infections. It is not known how long the virus can persist in the body, or whether it is capable of reactivation after long periods. In patients experiencing immunosuppression (e.g. AIDS) it can be reactivated, causing disease. Adenovirus vectors, particularly those based on Ad5, have shown great promise for the development of gene therapy protocols and have been used for clinical purpose.
Especificaciones
Especificaciones
| Especie | Virus |
| Método de purificación | purified |
| Nombre común | Adenovirus 9 E4-Orf1 |
| Concentración | 200 μg/mL |
| Contenido y almacenamiento | -20°C |
| Descripción | Synthetic Peptide |
| Formato | Liquid |
| Formulación | PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2 |
| Para utilizar con (aplicación) | Blocking Assay, Control |
| Liofilizado | No |
| Mostrar más |
Título del producto
Al hacer clic en Enviar, acepta que Fisher Scientific se ponga en contacto con usted en relación con los comentarios que ha proporcionado en este formulario. No compartiremos su información para ningún otro fin. Toda la información de contacto proporcionada se mantendrá de acuerdo con nuestra Política de Privacidad. Política de privacidad.
¿Detecta una oportunidad de mejora?